CIK 2054410
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 73.83% | 21 |
| Unclassified | 26.17% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | Unclassified | 26.17% | |
| 2 | CGON | CG Oncology, Inc. | Health Care | 21.77% |
| 3 | URGN | UroGen Pharma Ltd. | Health Care | 8.55% |
| 4 | PBYI | PUMA BIOTECHNOLOGY, INC. | Health Care | 7.50% |
| 5 | TRVI | Trevi Therapeutics, Inc. | Health Care | 7.27% |
| 6 | CADL | Candel Therapeutics, Inc. | Health Care | 4.89% |
| 7 | BCAX | Bicara Therapeutics Inc. | Health Care | 3.64% |
| 8 | OKUR | OnKure Therapeutics, Inc. | Health Care | 3.34% |
| 9 | JBIO | Jade Biosciences, Inc. | Health Care | 3.14% |
| 10 | TARA | Protara Therapeutics, Inc. | Health Care | 2.59% |
21/22 names classified · sector 73.8% of weight · industry 73.8% · mkt cap 73.8%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 73.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 9% of book weight classified — the grid is NOT representative of the whole book.
Classified: 9.2% of book weight (3/22 names) · unclassified 90.8%: , CGON, URGN, TRVI, CADL, BCAX, OKUR, JBIO, TARA, VSTM +9 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | 1,746,264 | $92M | 26.2% | HOLD |
| 2 | CGONCG ONCOLOGY INC | 1,130,501 | $77M | 21.8% | HOLD |
| 3 | URGNUROGEN PHARMA LTD | 1,673,420 | $30M | 8.6% | ADD 16% |
| 4 | PBYIPUMA BIOTECHNOLOGY INC | 4,131,299 | $26M | 7.5% | HOLD |
| 5 | TRVITREVI THERAPEUTICS INC | 2,144,844 | $26M | 7.3% | HOLD |
| 6 | CADLCANDEL THERAPEUTICS INC | 3,497,948 | $17M | 4.9% | ADD 36% |
| 7 | BCAXBICARA THERAPEUTICS INC | 643,382 | $13M | 3.6% | HOLD |
| 8 | OKURONKURE THERAPEUTICS INC | 2,839,674 | $12M | 3.3% | HOLD |
| 9 | JBIOJADE BIOSCIENCES INC | 786,760 | $11M | 3.1% | NEW |
| 10 | TARAPROTARA THERAPEUTICS INC | 1,752,115 | $9M | 2.6% | HOLD |
| 11 | VSTMVERASTEM INC | 1,469,153 | $8M | 2.2% | HOLD |
| 12 | HELPCYBIN INC | 1,540,266 | $7M | 2.1% | TRIM −2% |
| 13 | LONALEONABIO INC | 634,539 | $7M | 1.9% | ADD 26% |
| 14 | AURAAURA BIOSCIENCES INC | 595,744 | $4M | 1.1% | HOLD |
| 15 | WHWKWHITEHAWK THERAPEUTICS INC | 1,139,363 | $4M | 1.1% | HOLD |
| 16 | CRDFCARDIFF ONCOLOGY INC | 1,762,084 | $3M | 0.8% | TRIM −10% |
| 17 | QTTBQ32 BIO INC | 315,052 | $2M | 0.6% | TRIM −36% |
| 18 | KPTIKARYOPHARM THERAPEUTICS INC | 287,826 | $2M | 0.5% | NEW |
| 19 | JSPRJASPER THERAPEUTICS INC | 1,411,492 | $1M | 0.4% | TRIM −21% |
| 20 | XFORX4 Pharmaceuticals, Inc. | 234,039 | $966,583 | 0.3% | TRIM −14% |
| 21 | BCABBIOATLA INC | 5,406,345 | $865,015 | 0.2% | ADD 12% |
| 22 | VYNEVYNE THERAPEUTICS INC | 1,425 | $855 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC | 2.0M | 2.0M | 2.0M | 2.0M | 1.7M | 1.7M | $92M |
| CGONCG ONCOLOGY INC | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | $77M |
| URGNUROGEN PHARMA LTD | 1.5M | 1.5M | 1.3M | 1.3M | 1.4M | 1.7M | $30M |
| PBYIPUMA BIOTECHNOLOGY INC | 3.9M | 3.9M | 4.1M | 4.1M | 4.1M | 4.1M | $26M |
| TRVITREVI THERAPEUTICS INC | 2.0M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | $26M |
| CADLCANDEL THERAPEUTICS INC | 1.9M | 2.2M | 2.6M | 2.6M | 2.6M | 3.5M | $17M |
| BCAXBICARA THERAPEUTICS INC | 643K | 643K | 643K | 643K | 643K | 643K | $13M |
| OKURONKURE THERAPEUTICS INC | 1.4M | 1.4M | 2.8M | 2.8M | 2.8M | 2.8M | $12M |
| JBIOJADE BIOSCIENCES INC | — | — | — | — | — | 787K | $11M |
| TARAPROTARA THERAPEUTICS INC | 1.3M | 1.3M | 1.8M | 1.8M | 1.8M | 1.8M | $9M |
| VSTMVERASTEM INC | 779K | 779K | 779K | 779K | 1.5M | 1.5M | $8M |
| HELPCYBIN INC | 734K | 734K | 734K | 734K | 1.6M | 1.5M | $7M |
| LONALEONABIO INC | — | — | — | — | 502K | 635K | $7M |
| AURAAURA BIOSCIENCES INC | — | 591K | 596K | 596K | 596K | 596K | $4M |
| WHWKWHITEHAWK THERAPEUTICS INC | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | $4M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
